NCT03709693View on ClinicalTrials.gov

Clinical Outcomes in Patients Treated With SternaLock Blu

TerminatedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

May 13, 2020

Study Completion Date

May 13, 2020

Conditions
Cardiac Surgical ProceduresCoronary Artery DiseaseHeart Valve Diseases
Interventions
DEVICE

SternaLock Blu

Sternal closure will be accomplished using SternaLock Blu plates and screws in combination with single-wire method of sternal reduction.

Trial Locations (4)

22908

University of Virginia, Charlottesville

38120

Cardiovascular Surgery Clinic, PLLC, Memphis

46032

St. Franciscan Health, Indianapolis

64111

Saint Luke's Hospital of Kansas City, Kansas City

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT03709693 - Clinical Outcomes in Patients Treated With SternaLock Blu | Biotech Hunter | Biotech Hunter